C21 Investments Reports Strong Q2 Growth in Nevada

C21 Investments (TSE:CXXI) has released an update.

C21 Investments Inc. reports a strong performance in Q2, with its new dispensary in South Reno significantly contributing to a 14% increase in sales compared to the previous quarter. The dispensary achieved notable sales growth from $273,000 in July to $417,000 in September, highlighting the company’s expanding footprint in Nevada’s cannabis market. With these results, C21 is well-positioned to continue scaling operations and enhancing its market presence.

For further insights into TSE:CXXI stock, check out TipRanks’ Stock Analysis page.